Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 22.06
(-0.68%)
CNY 22.06
(-0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.8 Billion | 2.14 Billion | 2.05 Billion | 1.64 Billion | 938.58 Million | 737.25 Million |
| Net Income | 1.6 Billion | 1.35 Billion | 1.62 Billion | 1.14 Billion | 530.67 Million | 339.02 Million |
| Depreciation & Amortization | 1 Billion | 696.17 Million | 497.92 Million | 375.16 Million | 317.66 Million | 211.69 Million |
| Deferred income taxes | -63.63 Million | -177.17 Million | -67.52 Million | 28.44 Million | -11.52 Million | 13.66 Million |
| Stock-based compensation | 202.22 Million | 177.17 Million | 67.52 Million | 62.45 Million | 11.52 Million | - |
| Change in working capital | 63.66 Million | -346.46 Million | 130.03 Million | 234.58 Million | -61.11 Million | 43.07 Million |
| Other non-cash items | 2.14 Billion | 440.96 Million | -189.99 Million | -199.03 Million | 151.36 Million | 143.46 Million |
| Investing Cash Flow | -1.34 Billion | -2.2 Billion | -5.25 Billion | -3.37 Billion | -1.04 Billion | -714.6 Million |
| Investments in PPE | -2.86 Billion | -2.94 Billion | -2.09 Billion | -1.31 Billion | -754.6 Million | -640.98 Million |
| Acquisitions | 961.36 Million | -1.02 Billion | -1.23 Billion | -791.52 Million | -59.49 Million | 22.38 Million |
| Investment purchases | -2.11 Billion | -2.33 Billion | -4.92 Billion | -2.63 Billion | -693.94 Million | -95.99 Million |
| Sales/Maturities of investments | 2.67 Billion | 4.09 Billion | 2.98 Billion | 1.39 Billion | 491.34 Million | - |
| Other Investing Activities | -667.5 Thousand | 3.15 Million | 5.48 Million | -18.54 Million | -28.5 Million | 22.38 Million |
| Financing Cash Flow | 2.96 Billion | -1.41 Billion | 3.66 Billion | -280.17 Million | 4.24 Billion | -15.55 Million |
| Debt repayment | -3.61 Billion | -612.57 Million | -158.55 Million | -760.96 Million | -1.28 Billion | -423.68 Million |
| Dividends payments | -357.34 Million | -354.19 Million | -237.54 Million | -119.13 Million | -72.19 Million | -74.59 Million |
| Common Stock Repurchased | -830.02 Thousand | -393.38 Million | -284.05 Million | 13.14 Million | -5.05 Billion | - |
| Common Stock Issuance | -207.94 Million | 7.29 Million | -295.54 Million | -13.14 Million | 5.05 Billion | - |
| Other Financing Activities | 7.13 Billion | -13.83 Million | 4.68 Billion | 616.18 Million | 5.67 Billion | 482.71 Million |
| Accounts receivables | -480.1 Million | -786.73 Million | -216.3 Million | -95.34 Million | -286.41 Million | -173.77 Million |
| Accounts payables | 461.33 Million | 78.8 Million | 114.7 Million | 421.53 Million | 8.07 Million | 231.47 Million |
| Inventory | 82.42 Million | -120.89 Million | -224.87 Million | -120.04 Million | -37.95 Million | -28.28 Million |
| Other working capital | -1.00 | 482.35 Million | 456.51 Million | 28.44 Million | 255.17 Million | 71.36 Million |
| Cash at beginning of period | 1.49 Billion | 2.76 Billion | 2.35 Billion | 4.44 Billion | 307.23 Million | 293.6 Million |
| Cash at end of period | 5.91 Billion | 1.35 Billion | 2.76 Billion | 2.35 Billion | 4.44 Billion | 307.23 Million |
| Capital Expenditure | -2.86 Billion | -2.94 Billion | -2.09 Billion | -1.31 Billion | -754.6 Million | -640.98 Million |
| Effect of forex changes on cash | 11.43 Million | 72.99 Million | -45.51 Million | -85.66 Million | -4.27 Million | 6.53 Million |
| Net cash flow / Change in cash | 4.42 Billion | -1.4 Billion | 415.77 Million | -2.08 Billion | 4.13 Billion | 13.63 Million |
| Free Cash Flow | -62.3 Million | -807.04 Million | -34.77 Million | 332.77 Million | 183.98 Million | 96.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 308.39 Million | 882.84 Million | 230.55 Million | 1.6 Billion | 462.05 Million | 352.94 Million |
| Depreciation & Amortization | - | 277.4 Million | 277.4 Million | 1 Billion | 263.44 Million | -440.91 Million |
| Deferred income taxes | - | - | - | -63.63 Million | - | 929.29 Million |
| Stock-based compensation | - | 75.37 Million | 32.91 Thousand | 202.22 Million | 57 Million | 19.87 Million |
| Change in working capital | - | -62.85 Million | - | 63.66 Million | -195.45 Million | 240.93 Million |
| Other non-cash items | 476.67 Million | -240.83 Million | 520.82 Million | 2.14 Billion | 11.56 Million | -352.94 Million |
| Investing Cash Flow | -886.79 Million | 445.95 Million | -472.84 Million | -1.34 Billion | -455.9 Million | -989.92 Million |
| Investments in PPE | -548.87 Million | -451.59 Million | -498.61 Million | -2.86 Billion | -624.78 Million | -739.73 Million |
| Acquisitions | -22.47 Million | 186.26 Thousand | 81.18 Thousand | 961.36 Million | 1.62 Million | 1.18 |
| Investment purchases | -322.19 Million | -336.68 Million | -1.07 Billion | -2.11 Billion | -439.63 Million | -260.8 Million |
| Sales/Maturities of investments | 12.69 Million | 1.23 Billion | 1.1 Billion | 2.67 Billion | 606.21 Million | 4.95 Million |
| Other Investing Activities | -28.41 Million | 908.03 Million | 31.52 Million | -667.5 Thousand | 667.5 Thousand | 5.64 Million |
| Financing Cash Flow | -132.92 Million | -3.14 Billion | -1.51 Billion | 2.96 Billion | 3.48 Billion | -209.97 Million |
| Debt repayment | -78.99 Million | -2.6 Billion | -1.4 Billion | -3.61 Billion | -3.58 Billion | -110.86 Million |
| Dividends payments | -109.63 Million | -343.2 Million | -46.3 Million | -357.34 Million | -49.66 Million | -368.09 Million |
| Common Stock Repurchased | 151.12 Million | -151.12 Million | - | -830.02 Thousand | -830.02 Thousand | -860 Million |
| Common Stock Issuance | - | - | - | -207.94 Million | -515.62 Million | 860 Million |
| Other Financing Activities | -102.28 Million | 71.1 Million | -106.64 Million | 7.13 Billion | 7.63 Billion | 268.99 Million |
| Accounts receivables | - | 36.37 Million | - | -480.1 Million | -480.1 Million | 285.11 Million |
| Accounts payables | - | - | - | 461.33 Million | - | - |
| Inventory | - | -174.63 Million | - | 82.42 Million | 82.42 Million | -44.18 Million |
| Other working capital | - | 75.4 Million | - | -1.00 | 202.22 Million | -125.33 Million |
| Cash at beginning of period | 2.28 Billion | 4.63 Billion | 5.91 Billion | 1.49 Billion | 2.05 Billion | 2.47 Billion |
| Cash at end of period | 1.93 Billion | 2.4 Billion | 4.63 Billion | 5.91 Billion | 5.91 Billion | 2.02 Billion |
| Capital Expenditure | -548.87 Million | -451.59 Million | -498.61 Million | -2.86 Billion | -624.78 Million | -739.73 Million |
| Effect of forex changes on cash | -2.32 Million | 51.17 Million | 6.45 Million | 11.43 Million | 1.32 Million | -2.03 Million |
| Net cash flow / Change in cash | -351.26 Million | -2.23 Billion | -1.28 Billion | 4.42 Billion | 3.86 Billion | -452.73 Million |
| Free Cash Flow | 236.19 Million | -86.99 Million | 252.76 Million | -62.3 Million | 112.29 Million | 9.46 Million |
301011
9039
1259
CENTURYTEX
UNOMINDA
PRKA